Cargando…
Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
Raltegravir, an inhibitor of human immunodeficiency virus-1 (HIV-1) integrase, has been used to treat HIV/acquired immunodeficiency syndrome; however, its therapeutic effects on pulmonary fibrosis have not been investigated. In this study, the in vitro effects of raltegravir (RAV) on transforming gr...
Autores principales: | Zhang, Xue, Huang, Haidi, Zhang, Guanghua, Li, Defang, Wang, Hongbo, Jiang, Wanglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710384/ https://www.ncbi.nlm.nih.gov/pubmed/31481891 http://dx.doi.org/10.3389/fphar.2019.00903 |
Ejemplares similares
-
Tirbanibulin Attenuates Pulmonary Fibrosis by Modulating Src/STAT3 Signaling
por: Wang, Xin, et al.
Publicado: (2021) -
The protective role of raltegravir in experimental acute lung injury in vitro and in vivo
por: Xu, Zehui, et al.
Publicado: (2022) -
Saquinavir plus methylprednisolone ameliorates experimental acute lung injury
por: Zhang, Guanghua, et al.
Publicado: (2018) -
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
por: Huang, Jizhen, et al.
Publicado: (2020) -
Omaveloxolone inhibits IL-1β-induced chondrocyte apoptosis through the Nrf2/ARE and NF-κB signalling pathways in vitro and attenuates osteoarthritis in vivo
por: Jiang, Zengxin, et al.
Publicado: (2022)